Assignee
PARKER INST FOR CANCER IMMUNOTHERAPY
US·2 granted patents·2 pending applications·1 citations·filing 2022–2024
Top patents by PatentIndex Score
4 records- 0189US12221469B2Switch receptors using IL-9 signaling domainsPARKER INST FOR CANCER IMMUNOTHERAPY·Filed 2023·Granted Feb 11, 2025·1 cites·20 claims
- 0281US2025136664A1Switch receptors using il-9 signaling domainsPARKER INST FOR CANCER IMMUNOTHERAPY·Filed 2024·Application pending·0 cites
- 0380US2025179148A1Nucleic acids encoding switch receptors using il-9 receptor signaling domainsPARKER INST FOR CANCER IMMUNOTHERAPY·Filed 2024·Application pending·0 cites
- 0476US12202884B2Nucleic acids encoding switch receptors using IL-9 receptor signaling domainsPARKER INST FOR CANCER IMMUNOTHERAPY·Filed 2022·Granted Jan 21, 2025·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when PARKER INST FOR CANCER IMMUNOTHERAPY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →